Eric Easom
Fundador en AN2 THERAPEUTICS, INC. .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Eric Easom
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/11/2019 | - |
| Director Ejecutivo | 01/11/2019 | - | |
| Fundador | 01/02/2017 | - | |
| Presidente | 01/11/2019 | - | |
| Chagas Disease Foundation | Director/Miembro de la Junta | 01/06/2018 | - |
Resilient Biotics, Inc.
 Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Director/Miembro de la Junta | 01/02/2019 | - |
Historial de carrera de Eric Easom
Antiguos cargos conocidos de Eric Easom.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/02/2009 | 01/06/2017 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Director/Miembro de la Junta | 01/01/2013 | 01/01/2014 |
| Presidente | 01/01/2009 | 01/01/2013 | |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Ventas & Marketing | 01/07/2007 | 01/01/2009 |
| Medimmune, Inc. | Ventas & Marketing | 01/04/2006 | 01/07/2007 |
Formación de Eric Easom.
| Kelley School of Business | Masters Business Admin |
| University of Louisville | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Director/Board Member | 4 |
| Sales & Marketing | 2 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
| Chagas Disease Foundation | |
Resilient Biotics, Inc.
Resilient Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA. | Commercial Services |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Eric Easom
- Experiencia